fundvisualizer.com

Patient Opportunity RLMORX

Performance (before sales charge)

As of 06/30/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 03/31/2024
Stock
88.80%
Non-U.S. Stock
11.19%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.01%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 03/31/2024

Basic materials

0.00%

Consumer cyclical

29.92%

Financial services

22.37%

Real estate

0.00%

Consumer defensive

0.00%

Health care

12.42%

Utilities

0.00%

Communication services

12.59%

Energy

9.63%

Industrials

6.80%

Technology

6.16%

Top 10 holdings

As of 03/31/2024

Amazon.com Inc
5.47%
Citigroup Inc
5.26%
Expedia Group Inc
4.50%
OneMain Holdings Inc
4.40%
Alphabet Inc Class A
4.26%
Delta Air Lines Inc
4.24%
Energy Transfer LP
4.21%
General Motors Co
3.91%
Meta Platforms Inc Class A
3.75%
UBS Group AG
3.56%
Fund assets

$1.44 Billion

Share class

Retirement

Morningstar category

Mid-Cap Blend

Expense ratio

2.37%

Investment objective

Growth

Documents